References

1. Gillespie, M.B. and D.W. Eisele, CHAPTER 20 - Complications of Surgery of the Salivary Glands , in Complications in Head and Neck Surgery (Second Edition) , D.W. Eisele and R.V. Smith, Editors. 2009, Mosby: Philadelphia. p. 221-239.
2. Kontis, T.L., V., Neurotoxin Injection for Gustatory Sweating , in Cosmetic Injection Techniques: A Text and Video Guide to Neurotoxins and Fillers . 2013, Thieme: New York, Stuttgart. p. 74f.
3. Motz, K.M. and Y.J. Kim, Auriculotemporal Syndrome (Frey Syndrome). Otolaryngologic clinics of North America, 2016.49 (2): p. 501-509.
4. de Bree, R., I. van der Waal, and C.R. Leemans, Management of Frey syndrome. Head Neck, 2007. 29 (8): p. 773-8.
5. Yoo, Y.M., et al., Dermofat graft after superficial parotidectomy via a modified face-lift incision to prevent Frey syndrome and depressed deformity. J Craniofac Surg, 2011. 22 (3): p. 1021-3.
6. Bianchi, B., et al., Improving esthetic results in benign parotid surgery: statistical evaluation of facelift approach, sternocleidomastoid flap, and superficial musculoaponeurotic system flap application. J Oral Maxillofac Surg, 2011. 69 (4): p. 1235-41.
7. Kim, I.K., et al., Facelift incision and superficial musculoaponeurotic system advancement in parotidectomy: case reports.Maxillofac Plast Reconstr Surg, 2015. 37 (1): p. 40.
8. Torretta, S., et al., Fat injections for the management of post-parotidectomy Frey syndrome: a technical note. J Craniomaxillofac Surg, 2012. 40 (2): p. 173-6.
9. Costa, A.P., E.; Pereira, M.; Santos, F.; Favaro, R.; Stocco, P.; Arruda, L., Comparative study of the diffusion of five botulinum toxins type-A in five dosages of use: Are there differences amongst the commercially-available products? escholarship, 2012.
10. Guntinas-Lichius, O., Increased botulinum toxin type A dosage is more effective in patients with Frey’s syndrome. Laryngoscope, 2002.112 (4): p. 746-9.
11. Dai, X.M., et al., Prevention of Frey Syndrome With Temporal Fascia Flap in Parotidectomy. Ann Plast Surg, 2015. 75 (6): p. 610-4.
12. Dulguerov, N., A. Makni, and P. Dulguerov, The superficial musculoaponeurotic system flap in the prevention of Frey syndrome: A meta-analysis. Laryngoscope, 2016. 126 (7): p. 1581-4.
13. Choi, J., et al., Acellular dermal matrix (Insuregraf) in the prevention of Frey’s syndrome and surgical site depression after parotidectomy. Arch Craniofac Surg, 2019. 20 (3): p. 176-180.
14. Aizawa, T., et al., Polyglycolic Acid Felt for Prevention of Frey Syndrome After Parotidectomy. Ann Plast Surg, 2018.81 (4): p. 438-440.
15. Ghassemi, A., et al., Vascularised fatty tissue: its role in prevention of the symptoms of Frey syndrome after parotidectomy. Br J Oral Maxillofac Surg, 2018. 56 (9): p. 877-880.